A clinical study of plasma derived anti-COVID-19 immunoglobulin to prevent COVID-19 disease in healthy subjects at risk
Latest Information Update: 14 Aug 2020
At a glance
- Drugs Anti-COVID-19 immunoglobulin-Kamada (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions
- 14 Aug 2020 New trial record